SERPINB13 (NM_012397) Human Recombinant Protein
CAT#: TP311032
Recombinant protein of human serpin peptidase inhibitor, clade B (ovalbumin), member 13 (SERPINB13)
Specifications
Product Data | |
Species | Human |
Expression Host | HEK293T |
Expression cDNA Clone or AA Sequence |
Recombinant protein was produced with TrueORF clone, RC211032. Click on the TrueORF clone link to view cDNA and protein sequences.
|
Tag | C-Myc/DDK |
Predicted MW | 44.1 kDa |
Concentration | >50 ug/mL as determined by microplate BCA method |
Purity | > 80% as determined by SDS-PAGE and Coomassie blue staining |
Buffer | 25 mM Tris.HCl, pH 7.3, 100 mM glycine, 10% glycerol |
Preparation | Recombinant protein was captured through anti-DDK affinity column followed by conventional chromatography steps. |
Storage | Store at -80°C. |
Stability | Stable for 12 months from the date of receipt of the product under proper storage and handling conditions. Avoid repeated freeze-thaw cycles. |
Reference Data | |
RefSeq | NP_036529 |
Locus ID | 5275 |
UniProt ID | Q9UIV8 |
Cytogenetics | 18q21.33 |
Refseq Size | 3197 |
Refseq ORF | 1173 |
Synonyms | headpin; HSHUR7SEQ; HUR7; PI13 |
Summary | 'The protein encoded by this gene is a member of the serpin family of serine protease inhibitors. The encoded protein inhibits the activity of cathepsin K and is itself transcriptionally repressed by RUNX1. This gene is downregulated in many types of cancer. [provided by RefSeq, Jan 2017]' |
Protein Families | Druggable Genome, Transmembrane |
Documents
FAQs |
SDS |
Resources
Recombinant Protein Resources |
Other Versions
SKU | Description | Size | Price |
---|---|---|---|
LC415794 | SERPINB13 HEK293T cell transient overexpression lysate (as WB positive control) |
USD 121.00 |
|
LY415794 | Transient overexpression lysate of serpin peptidase inhibitor, clade B (ovalbumin), member 13 (SERPINB13) |
USD 396.00 |
|
PH311032 | SERPINB13 MS Standard C13 and N15-labeled recombinant protein (NP_036529) |
USD 2,055.00 |
{0} Product Review(s)
Be the first one to submit a review